Examples of Drug Product Batch in a sentence
Authorities 23 CFR 230.409 FHWA Form-1273 Types of Comprehensive Compliance Reviews NDOT performs two types of Comprehensive Compliance Reviews: project-based and contractor-based.
BI Pharma may conduct a Review by: (i) reviewing the Certificate of Analysis and the Manufacturing Documentation and such other documents, if any, as BI Pharma may request; and (ii) conducting acceptance testing of a representative sample of the Drug Product Batch.
For each Drug Product Batch to be delivered to BI Pharma or to a recipient designated by BI Pharma, ImmunoGen shall prepare and submit a representative sample of such Drug Product Batch, and a Certificate of Analysis that identifies the items tested, the applicable specifications and test results.
Moreover, the foregoing applies only if nonconformance is detected prior to the expiry date of the Drug Product Batch.
The authorities conferred on the Office and the Director by this chapter shall be ex- ercised in a manner consistent with provi- sions of the National Security Act of 1947 (50U.S.C. 401 et seq.).
In the event that any Drug Product Batch after delivery to BI Pharma is detected to fail to comply with the Final Specifications, ImmunoGen shall, at its own cost (a) deliver replacement quantities of such Drug Product to BI Pharma or make up the shortage, as the case may be, [ * ]; or (b) if replacement is not possible despite ImmunoGen's [ * ], at BI Pharma's discretion, either refund or credit BI Pharma's account for the amount paid for such Drug Product.
Prior to delivery to BI Pharma, ImmunoGen shall test, or cause to be tested, a representative sample of each Drug Product Batch (or components as applicable) to demonstrate that such Drug Product Batch complies with the applicable specifications (manufacturer's release).
Lonza shall not be responsible for the cost of Raw Materials, Customer Materials and/or starting materials consumed in any Failed Drug Substance Batch or Failed Drug Product Batch except to the extent set forth in Clause 7.5.3.
In the event that any Drug Product Batch after [ * ] to BI Pharma is [ * ] to [ * ] to [ * ] with the [ * ], ImmunoGen shall, [ * ] (a) [ * ] of such Drug Product to BI Pharma or [ * ] the [ * ], as the case may be, [ * ]; or (b) if [ * ] is not possible [ * ], at [ * ], either [ * ] or [ * ] for the [ * ] for such Drug Product.
Prior to delivery to BI Pharma, ImmunoGen shall test, or cause to be tested, a representative sample of each Drug Product Batch (or components as applicable) to demonstrate that such Drug Product Batch complies with the applicable specifications (manufacturer’s release).